Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-054623

Options or other derivatives

  • Chief Medical Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gordon David N. Chief Medical Officer 2019-10-30 Grant or award · Restricted stock units +175,000 175,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…